Driehaus Small/Mid Cap Growth holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
Driehaus Small/Mid Cap Growth Fund DSMDX
- NAV / 1-Day Return 21.24 / +0.85 %
- Total Assets 101.3M
-
Adj. Expense Ratio
0.800%
- Expense Ratio 0.790%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Open
- TTM Yield 0.40%
- Turnover 152%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:27 AM GMT+0
Morningstar’s Analysis DSMDX
Will DSMDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Northern Institutional US Government | 2.95 | 3M | Cash and Equivalents |
Crinetics Pharmaceuticals Inc | 2.54 | 2M | Healthcare |
Guardant Health Inc | 2.51 | 2M | Healthcare |
Natera Inc | 1.91 | 2M | Healthcare |
Praxis Precision Medicines Inc Ordinary Shares | 1.90 | 2M | Healthcare |
Carpenter Technology Corp | 1.70 | 2M | Industrials |
Curtiss-Wright Corp | 1.65 | 2M | Industrials |
Teledyne Technologies Inc | 1.47 | 1M | Technology |
Affirm Holdings Inc Ordinary Shares - Class A | 1.41 | 1M | Financial Services |
Arrowhead Pharmaceuticals Inc | 1.38 | 1M | Healthcare |